目次
A short history of vaccination -- Vaccine immunology -- Correlates of protection -- The vaccine industry -- Vaccine manufacturing -- Evolution of adjuvants across the centuries -- Vaccine additives and manufacturing residuals in vaccines licensed in the united states -- Passive immunization -- General immunization practices -- Adenovirus vaccines -- Anthrax vaccines -- Biodefense and special pathogen vaccines -- Cancer vaccines -- Cholera vaccines -- Combination vaccines -- Cytomegalovirus vaccines -- Dengue vaccines -- Diarrhea caused by bacteria -- Diphtheria toxoid -- Ebola vaccines -- Enterovirus 71 -- Epstein-Barr virus vaccines -- Haemophilus influenzae type b vaccines -- Hepatitis A vaccines -- Hepatitis B vaccines -- Hepatitis C vaccines -- Hepatitis E vaccines -- Herpes simplex virus vaccines -- Human immunodeficiency virus vaccines -- Human papillomavirus vaccines -- Inactivated influenza vaccines -- Influenza vaccine -- live -- Japanese encephalitis vaccines --
Lyme disease vaccines -- Malaria vaccines -- Maternal immunization -- Measles vaccines -- Meningococcal capsular group A, C, W, and Y conjugate vaccines -- Meningococcal capsular group B vaccines -- Mumps vaccines -- Noninfectious disease vaccines -- Norovirus vaccines -- Parasitic disease vaccines -- Pertussis vaccines -- Plague vaccines -- Pneumococcal conjugate vaccine and pneumococcal common protein vaccines -- Pneumococcal polysaccharide vaccines -- Poliovirus vaccine-inactivated -- Poliovirus vaccine-live -- Rabies vaccines -- Respiratory syncytial virus vaccines -- Rotavirus vaccines -- Rubella vaccines -- Smallpox and vaccinia -- Staphylococcus aureus vaccines -- Streptococcus group a vaccines -- Streptococcus group B vaccines -- Tetanus toxoid -- Tickborne encephalitis vaccines -- Tuberculosis vaccines -- Typhoid fever vaccines -- Varicella vaccines -- Yellow fever vaccines -- Zika virus -- Zoster vaccines -- Technologies for making new vaccines --
Development of gene-based vectors for immunization -- Technologies to improve immunization -- Vaccination of immunocompromised hosts -- Vaccination of human immunodeficiency virus-infected persons -- Vaccines for international travel -- Vaccines for healthcare personnel -- Immunization in the united states -- Immunization in Europe -- Immunization in the Asia-Pacific region -- Immunization in developing countries -- Community protection -- Economic analyses of vaccine policies -- Regulation and testing of vaccines -- Regulation of vaccines in Europe -- Regulation of vaccines in low- and middle-income countries -- Vaccine safety -- Legal issues -- Ethics
